why choose us

Clinical Trials Search

Showing 19,560 of 132,963 result(s)
ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Status: Completed

Condition: Endometrial Cancer

Interventions: 10 mg;kg- 20 mg;kg Atezolizumab will be administered by intravenous, on day 1 of each 21-day cycle.

Date: 2022-09-12

Eating Experience at the Comprehensive Cancer Center Wards - a Qualitative Study

Status: Completed

Condition: Cancer

Interventions: The Patient-Generated Subjective Global Assessment (PG-SGA) Short Form will be filled in by the participants.
Next, a semi-structured in-depth in

Date: 2022-09-12

Efficacy of Postoperative Telerehabilitation in Adolescent Idiopathic Scoliosis

Status: Active, not recruiting

Condition: Adolescent Idiopathic Scoliosis

Interventions: Interventional

Date: 2022-09-12

Feasibility and Efficacy of a Brief Digital Self-efficacy Training

Status: Completed

Condition: Stress
Self Efficacy

Interventions: Interventional

Date: 2022-09-12

The Effect of Model-Based PMR Training on Anxiety and Blood Sugar Levels to Women With Gestational Diabetes

Status: Completed

Condition: Gestational Diabetes Mellitus in Pregnancy
Anxiety in Pregnancy

Interventions: Interventional

Date: 2022-09-12

The Duration of Antibiotic Therapy for Early (DATE) Ventilator Associated Pneumonia (VAP): 4 vs. 7 Days

Status: Completed

Condition: Ventilator Associated Pneumonia

Interventions: Antibiotics will be administered as per the standard of care orally via tablet

Date: 2022-09-12

Trial of Zolpidem for Sleep in Children With Autism

Status: Completed

Condition: Autism

Interventions: 5mg (and up to10mg) Diphenhydramine given orally

Date: 2022-09-12

Postoperative Urinary Retention in Patients After Noncardiac Surgery and Reversal of Neuromuscular Block

Status: Completed

Condition: Neuromuscular Blockade

Interventions: Administration by intravenous infusion

Date: 2022-09-12

Trial of Suvorexant for Sleep in Children With Autism

Status: Completed

Condition: Autism

Interventions: 5 mg (and up to 20 mg) Suvorexant given orally

Date: 2022-09-12

A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications

Status: Completed

Condition: Movement Disorders

Interventions: Unilateral pallidotomy using focused ultrasound for the treatment of Parkinson's Disease with medication-refractory moderate to severe motor comp

Date: 2022-09-12